Izafe Group
0.26
SEK
+2.36 %
Less than 1K followers
IZAFE B
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
+2.36%
+14.04%
+21.5%
+8.33%
+28.71%
+13.04%
-56.67%
-85.96%
-92.51%
iZafe Group is a Life Science company focused on the development and marketing of digital medical solutions. The company offers products such as Dosell, a pharmaceutical robot, and the SaaS solution Pilloxa, a connected dose bag. The products aim to reduce the risk of incorrect medication. The customers are private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group has its headquarters in Stockholm.
Read moreMarket cap
83.65M SEK
Turnover
51.98K SEK
Revenue
7.95M
EBIT %
-244.4 %
P/E
-
Dividend yield-%
-
Financial calendar
25.4
2025
Interim report Q1'25
28.5
2025
General meeting '25
29.8
2025
Interim report Q2'25
ShowingAll content types
iZafe Group's Board Member Magnus Engman Purchases 200,000 Shares
Launch of Dosell sales in Spain – A groundbreaking solution to improve medication adherence
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools